Immunoaffinity Chromatography Market Share

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. Presently, the immunoaffinity chromatography market in North America industry is poised to hold largest revenue share by 2036, on account of extensive R&D activities for the development of cancer drugs and biologics. Since the prevalence of cancer has increased in the region, there have been high investments in research and development by life sciences companies for the development of better-performing drugs. This is also a key factor contributing to the market’s growth in the region. According to the WHO, more than 2.2 million new cancer cases were recorded in the United States in 2020. Out of the total cancer cases, the prevalence of breast, lung, and prostate cancer was relatively high compared to other cancer forms, accounting for approximately 11.1%, 10%, and 9.2%, respectively. Asia-Pacific is anticipated to be the fastest-growing region on account of the improving economic conditions in countries such as India, China, Malaysia, and others accompanied by growing healthcare expenditure. Besides, the increasing cancer research & development activities in the region are also projected to create a surge in demand for immunoaffinity chromatography. Asia-Pacific region holds an estimated 50% of the world's new cancer cases annually.